Select a page
  • Home
  • Blogs
  • About IBR
    • The Magazine
    • Sponsor
  • Archive
    • Past Issues
    • Article & Blog Database
  • Join IBR
  • Home
  • Blogs
  • About IBR
    • The Magazine
    • Sponsor
  • Archive
    • Past Issues
    • Article & Blog Database
  • Join IBR

Spring 2010

The Big Pharma Bust

The collapse of Western pharmaceutical companies is inevitable
April 3, 2010 | Juthika Thakur

TAGS
Corporate Strategy Eli Lilly Healthcare and Pharmaceuticals Pfizer Pharmaceuticals Novartis Asia Merck China Sanofi-Aventis India GlaxoSmithKline Published Dr. Reddy's Laboratories Volume 1 Piramal Enterprises Spring 2010 Cipla Natasha Neal Biocon Juthika Thakur
CONTACT THE AUTHOR
Juthika Thakur
COMMENTS

Most Read Articles
Lego: Restructuring, Brick By Brick
by Jerry Wang and Eden Ip
Interview: Braden Ream, CEO of Voiceflow
by IBR Students
PayPal: Cashing in on Latin America
by Rahul Guggali and Kayla Pandza
Nintendo: Time To “Switch” It Up
by Sooruj Ghangass and Alif Karmali
Under Armour: The Only Way Is Through Brand Partnership
by Justin Li and Shivani Pradhan
Related Articles
The Perfect Remedy
by David Stewart and Sabriya Karim
The Biosimilar Onslaught
by Kevin Shi and Nawid Sayed
Teva: Don’t Be so Generic
by Sooruj Ghangass and Gordon Sun
Pfizer: Betting on Success
by Ethan Milne
The Battle Over Your Genes
by Lauren Lee
Gilead: Cultivating the Pipeline
by Jason Cheung and Dennis Zhan
About IBR

Ivey Business Review is written, designed, and managed by undergraduate students at the Ivey Business School and is the only publication of its kind in the country. IBR publishes two issues annually in December and April with content created exclusively by students and maintains an active blog, curated by the IBR Editorial Board, with contributions from students and young alumni.

IBR On Twitter
  • We are proud to announce the release of our Spring 2018 issue (https://t.co/rFKOrVi1kL ). Find articles proposing B… https://t.co/VaHpa9wO5n
  • We are proud to announce the release of our Fall 2017 edition, with articles such as a biosimilar strategy for Teva… https://t.co/khESwrfGmU
  • Our feature interview, @mhyattbluecat sold his company for $400M! Find out his thoughts on entrepreneurship here: https://t.co/PL7oqL7BcG
About Ivey

The Ivey Business School at Western University offers undergraduate (HBA) and graduate degree programs (MSc, MBA, Executive MBA and PhD) in addition to non-degree Executive Development programs.

Copyright ® 2020, Ivey Business School | Terms of Use & Privacy Policy